Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 121, Issue -, Pages 727-736Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2016.04.075
Keywords
GSK-3; CDK-2; Molecular docking; Molecular dynamics; SBDD
Categories
Funding
- Department of Science and Technology (DST), Govt. of India, New Delhi, India
- NIPER, S. A. S. Nagar
- University Grant Commission (UGC), Govt. of India, New Delhi, India [43395]
Ask authors/readers for more resources
In this work, iminothiazolidin-4-one derivatives were explored as selective GSK-3 beta inhibitors. Molecular docking analysis was carried to design a series of compounds, which were synthesized using substituted thiourea, 2-bromoacetophenones and benzaldehydes. Out of the twenty five compounds synthesized during this work, the in vitro evaluation against GSK-3 led to the identification of nine compounds with activity in lower nano-molar range (2-85 nM). Further, in vitro evaluation against CDK-2 showed five compounds to be selective towards GSK-3. (C) 2016 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available